Full Breakdown
Congress Advances Defense Bill with New Restrictions on China
12/12/2025, 6:36:17 AM
Legislative Overview and Key Provisions
The U.S. House of Representatives has passed a significant $900 billion National Defense Authorization Act (NDAA), which includes provisions aimed at countering China's influence and military capabilities. The bill, approved with a vote of 312-112, incorporates measures to scrutinize American investments in China, particularly in sensitive sectors such as biotechnology and advanced technologies, including artificial intelligence and quantum computing. Additionally, the legislation prohibits government funding for equipment and services from blacklisted Chinese biotechnology firms and increases support for Taiwan, which China claims as its territory.
Motivations Behind the Legislation
The push for these restrictions reflects a bipartisan consensus in Congress to address perceived threats from the Chinese Communist Party. Representative Raja Krishnamoorthi, the top Democrat on the House Select Committee on the Chinese Communist Party, emphasized that the measures represent a strategic approach to countering China, contrasting with the Trump administration's recent softer rhetoric towards Beijing. The NDAA also aims to enhance U.S. military support for Taiwan, including a proposed increase in funding for security cooperation from $300 million to $1 billion.
Official Responses and Criticism
The Chinese embassy in Washington has condemned the NDAA, with spokesperson Liu Pengyu stating that the bill perpetuates the "China threat" narrative and undermines China's sovereignty. Liu expressed strong opposition to the legislation, arguing it disrupts efforts to stabilize bilateral relations. Critics within the U.S. have also raised concerns about the implications of the bill, particularly regarding its potential to hinder innovation in biotechnology by limiting collaboration with Chinese firms. Previous attempts to pass similar legislation, such as the BIOSECURE Act, faced backlash for potentially stifling drug development and raising medication costs.
Broader Implications and Future Considerations
The NDAA's provisions signal a long-term commitment by Congress to maintain a competitive stance against China, regardless of the White House's diplomatic approach. Craig Singleton, a senior director at the Foundation for Defense of Democracies, noted that the bill would establish a foundational policy framework that future administrations would find challenging to alter. The legislation also includes measures to enhance U.S. military readiness and support for allies, urging countries like Japan and South Korea to increase their defense spending.
Conflicting Reports and Legislative Next Steps
While the NDAA has garnered bipartisan support, dissenting voices within Congress have raised issues regarding the bill's extensive spending and the rapid pace of its passage. Some lawmakers, including Rep. Tim Burchett, criticized the lack of time to review the 3,000-page document, suggesting that it contains provisions that may not align with conservative values. The bill now moves to the Senate for further consideration, where it may undergo additional scrutiny and amendments.
Verbatim Quotes
- “This legislation will help bring that to an end.” — Rep. John Moolenaar, Chair of the House Select Committee on the Chinese Communist Party
- “China strongly deplores and firmly opposes this,” — Liu Pengyu, Spokesperson for the Chinese Embassy in Washington
- “With the NDAA, President Trump and Congressional Republicans are restoring American strength, defending our homeland, standing with our allies, and ensuring the United States remains the most powerful and capable military force the world has ever known,” — House Speaker Mike Johnson (R-LA)
